138 related articles for article (PubMed ID: 32022621)
1. Metabolic tumor volume, cancer cell fraction, and prognosis - the case of T-cell/histiocyte-rich large B-cell lymphoma.
Schmitz C; Rekowski J; Reinke S; Müller SP; Hüttmann A; Klapper W; Dührsen U
Leuk Lymphoma; 2020 Jun; 61(6):1372-1379. PubMed ID: 32022621
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting.
Glynn E; Fromm JR
Cytometry B Clin Cytom; 2020 Jan; 98(1):88-98. PubMed ID: 31254446
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base.
Ollila TA; Reagan JL; Olszewski AJ
Leuk Lymphoma; 2019 Dec; 60(14):3426-3433. PubMed ID: 31287335
[TBL] [Abstract][Full Text] [Related]
4. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype.
Hartmann S; Tousseyn T; Döring C; Flüchter P; Hackstein H; Herreman A; Ponzoni M; de Wolf-Peeters C; Facchetti F; Gascoyne RD; Küppers R; Steidl C; Hansmann ML
Int J Cancer; 2013 Dec; 133(11):2609-18. PubMed ID: 23686423
[TBL] [Abstract][Full Text] [Related]
5. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
[TBL] [Abstract][Full Text] [Related]
6. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
[TBL] [Abstract][Full Text] [Related]
7. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Younes S; Subramanian A; Khan A; Zhao S; Binkley M; Natkunam Y
Blood Cancer J; 2024 May; 14(1):92. PubMed ID: 38821935
[TBL] [Abstract][Full Text] [Related]
8. T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification.
Tousseyn T; De Wolf-Peeters C
Virchows Arch; 2011 Dec; 459(6):557-63. PubMed ID: 22081105
[TBL] [Abstract][Full Text] [Related]
9. Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?
Hartmann S; Döring C; Jakobus C; Rengstl B; Newrzela S; Tousseyn T; Sagaert X; Ponzoni M; Facchetti F; de Wolf-Peeters C; Steidl C; Gascoyne R; Küppers R; Hansmann ML
PLoS One; 2013; 8(11):e78812. PubMed ID: 24244368
[TBL] [Abstract][Full Text] [Related]
10. T-cell/histiocyte-rich large B-cell lymphoma displays a heterogeneity similar to diffuse large B-cell lymphoma: a clinicopathologic, immunohistochemical, and molecular study of 30 cases.
Wang J; Sun NC; Chen YY; Weiss LM
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):109-15. PubMed ID: 15894921
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
12. Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial.
Schmitz C; Hüttmann A; Müller SP; Hanoun M; Boellaard R; Brinkmann M; Jöckel KH; Dührsen U; Rekowski J
Eur J Cancer; 2020 Jan; 124():25-36. PubMed ID: 31710995
[TBL] [Abstract][Full Text] [Related]
13. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
[TBL] [Abstract][Full Text] [Related]
14.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
15. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
16. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
17. 3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma.
Sadeghi Shoreh Deli A; Scharf S; Steiner Y; Bein J; Hansmann ML; Hartmann S
Mod Pathol; 2022 Oct; 35(10):1431-1438. PubMed ID: 35173297
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Zheng SM; Zhou DJ; Chen YH; Jiang R; Wang YX; Zhang Y; Xue HL; Wang HQ; Mou D; Zeng WZ
World J Gastroenterol; 2017 Jun; 23(24):4467-4472. PubMed ID: 28706431
[TBL] [Abstract][Full Text] [Related]
19. A case report of T cell/histiocyte-rich large B cell lymphoma misdiagnosed as lymphomatoid papulosis.
Kim T; Kim J; Park J
Medicine (Baltimore); 2023 Mar; 102(13):e33407. PubMed ID: 37000052
[TBL] [Abstract][Full Text] [Related]
20. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia.
Kunder C; Cascio MJ; Bakke A; Venkataraman G; O'Malley DP; Ohgami RS
Am J Clin Pathol; 2017 Jun; 147(6):596-603. PubMed ID: 28575178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]